Mariner LLC Reduces Holdings in Celsius Holdings, Inc. (NASDAQ:CELH)

Mariner LLC cut its stake in Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) by 47.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 50,479 shares of the company's stock after selling 45,596 shares during the quarter. Mariner LLC's holdings in Celsius were worth $1,330,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. grew its stake in Celsius by 2.2% during the fourth quarter. Vanguard Group Inc. now owns 15,813,110 shares of the company's stock worth $416,517,000 after buying an additional 345,837 shares in the last quarter. Alliancebernstein L.P. boosted its position in shares of Celsius by 11.2% during the 4th quarter. Alliancebernstein L.P. now owns 14,292,123 shares of the company's stock worth $376,455,000 after acquiring an additional 1,444,020 shares in the last quarter. FMR LLC increased its stake in Celsius by 64.2% in the fourth quarter. FMR LLC now owns 4,055,148 shares of the company's stock valued at $106,813,000 after acquiring an additional 1,585,839 shares during the last quarter. Contrarius Group Holdings Ltd acquired a new position in Celsius during the fourth quarter valued at approximately $75,535,000. Finally, Norges Bank bought a new stake in Celsius during the fourth quarter worth $72,579,000. 60.95% of the stock is owned by institutional investors.

Celsius Stock Performance

CELH traded down $0.47 during mid-day trading on Tuesday, reaching $35.46. 7,310,618 shares of the stock were exchanged, compared to its average volume of 7,793,372. The company has a 50 day moving average price of $32.59 and a two-hundred day moving average price of $29.50. Celsius Holdings, Inc. has a 1 year low of $21.10 and a 1 year high of $98.85. The stock has a market capitalization of $9.14 billion, a PE ratio of 80.59, a price-to-earnings-growth ratio of 2.90 and a beta of 1.58.

Celsius (NASDAQ:CELH - Get Free Report) last posted its earnings results on Thursday, February 20th. The company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.11 by $0.03. The firm had revenue of $332.20 million for the quarter, compared to analysts' expectations of $326.07 million. Celsius had a net margin of 10.70% and a return on equity of 51.89%. Sell-side analysts expect that Celsius Holdings, Inc. will post 0.89 EPS for the current fiscal year.

Insider Buying and Selling at Celsius

In related news, Director Joyce Russell sold 4,000 shares of the business's stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $28.47, for a total value of $113,880.00. Following the sale, the director now directly owns 19,106 shares in the company, valued at approximately $543,947.82. The trade was a 17.31 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Paul H. Storey sold 10,188 shares of the firm's stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $25.77, for a total value of $262,544.76. Following the completion of the transaction, the insider now directly owns 45,297 shares of the company's stock, valued at $1,167,303.69. The trade was a 18.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company's stock.

Wall Street Analyst Weigh In

CELH has been the subject of several research analyst reports. Stifel Nicolaus lowered their price target on shares of Celsius from $45.00 to $37.00 and set a "buy" rating for the company in a report on Monday, February 10th. TD Cowen downgraded shares of Celsius from a "buy" rating to a "hold" rating and dropped their price target for the stock from $40.00 to $29.00 in a research report on Wednesday, January 22nd. Needham & Company LLC upped their target price on Celsius from $40.00 to $45.00 and gave the company a "buy" rating in a research report on Wednesday, April 9th. Truist Financial raised shares of Celsius from a "hold" rating to a "buy" rating and increased their target price for the stock from $35.00 to $45.00 in a research note on Monday, March 31st. Finally, UBS Group upped their price objective on shares of Celsius from $43.00 to $48.00 and gave the company a "buy" rating in a report on Thursday, April 17th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $46.47.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.